Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus.

Brandler S, Lucas-Hourani M, Moris A, Frenkiel MP, Combredet C, Février M, Bedouelle H, Schwartz O, Desprès P, Tangy F.

PLoS Negl Trop Dis. 2007 Dec 12;1(3):e96.

2.

Overview of plant-derived vaccine antigens: Dengue virus.

Malabadi RB, Ganguly A, Silva JA, Parashar A, Suresh MR, Sunwoo H.

J Pharm Pharm Sci. 2011;14(3):400-13. Review.

3.

Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology.

Warter L, Appanna R, Fink K.

Immunol Res. 2012 Sep;53(1-3):148-61. doi: 10.1007/s12026-012-8268-8. Review.

PMID:
22434513
4.

Domain III of the envelope protein as a dengue vaccine target.

Guzman MG, Hermida L, Bernardo L, Ramirez R, Guillén G.

Expert Rev Vaccines. 2010 Feb;9(2):137-47. doi: 10.1586/erv.09.139. Review.

PMID:
20109025
5.
6.
7.

Prospects for a dengue virus vaccine.

Whitehead SS, Blaney JE, Durbin AP, Murphy BR.

Nat Rev Microbiol. 2007 Jul;5(7):518-28. Review.

PMID:
17558424
8.

Trials and tribulations on the path to developing a dengue vaccine.

Thomas SJ, Rothman AL.

Vaccine. 2015 Nov 27;33 Suppl 4:D24-31. doi: 10.1016/j.vaccine.2015.05.095. Epub 2015 Jun 27. Review.

PMID:
26122583
9.

The development of therapeutic antibodies against dengue virus.

Fibriansah G, Lok SM.

Antiviral Res. 2016 Apr;128:7-19. doi: 10.1016/j.antiviral.2016.01.002. Epub 2016 Jan 19. Review.

PMID:
26794397
10.

Live attenuated measles vaccine as a potential multivalent pediatric vaccination vector.

Tangy F, Naim HY.

Viral Immunol. 2005;18(2):317-26. Review.

PMID:
16035943
11.

Measles virus.

Naim HY.

Hum Vaccin Immunother. 2015;11(1):21-6. doi: 10.4161/hv.34298. Epub 2014 Nov 1. Review.

12.

Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms.

Rothman AL.

Nat Rev Immunol. 2011 Jul 15;11(8):532-43. doi: 10.1038/nri3014. Review.

PMID:
21760609
13.

Developing a dengue vaccine: progress and future challenges.

Thomas SJ.

Ann N Y Acad Sci. 2014 Sep;1323:140-59. doi: 10.1111/nyas.12413. Epub 2014 Apr 1. Review. Erratum in: Ann N Y Acad Sci. 2015 Mar;1338:115.

PMID:
24689974
14.

Antibody response to dengue virus.

Cedillo-Barrón L, García-Cordero J, Bustos-Arriaga J, León-Juárez M, Gutiérrez-Castañeda B.

Microbes Infect. 2014 Sep;16(9):711-20. doi: 10.1016/j.micinf.2014.07.011. Epub 2014 Aug 11. Review.

PMID:
25124542
15.

New vaccines for neglected parasitic diseases and dengue.

Beaumier CM, Gillespie PM, Hotez PJ, Bottazzi ME.

Transl Res. 2013 Sep;162(3):144-55. doi: 10.1016/j.trsl.2013.03.006. Epub 2013 Apr 8. Review.

PMID:
23578479
16.

The pathogenesis of dengue.

Yacoub S, Mongkolsapaya J, Screaton G.

Curr Opin Infect Dis. 2013 Jun;26(3):284-9. doi: 10.1097/QCO.0b013e32835fb938. Review.

PMID:
23449140
17.

Utility, limitations, and future of non-human primates for dengue research and vaccine development.

Sariol CA, White LJ.

Front Immunol. 2014 Sep 24;5:452. doi: 10.3389/fimmu.2014.00452. eCollection 2014. Review.

18.

Trends in clinical trials of dengue vaccine.

Marimuthu P, Ravinder JR.

Perspect Clin Res. 2016 Oct-Dec;7(4):161-164. Review.

19.

Towards development of a universal dengue vaccine - How close are we?

Pang EL, Loh HS.

Asian Pac J Trop Med. 2017 Mar;10(3):220-228. doi: 10.1016/j.apjtm.2017.03.003. Epub 2017 Mar 6. Review.

Supplemental Content

Support Center